Corebridge Financial »

Eyepoint Pharmaceuticals shares owned by Corebridge Financial

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Corebridge Financial from 13F filings

Historical chart of Corebridge Financial investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Corebridge Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Corebridge Financial

Quarter filed Position value Share count Share price at filing
2025-03-31 $174k 32k 5.42
2024-12-31 $242k 33k 7.45

More positions owned by Corebridge Financial

Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Ssga Active Etf Tr Blackstone Senr (SRLN)
Blackrock Etf Trust Ii Ishares Aaa Clo (CLOA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Janus Detroit Str Tr B-bbb Clo Etf (JBBB)
Nrg Energy Com New (NRG)

View all positions for Corebridge Financial

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
Adage Capital Partners GP
BlackRock
Federated Investors
Franklin Resources
Vanguard Group
TCG Crossover Management
Citadel Advisors
Paradigm Biocapital Advisors
OrbiMed Advisors
Geode Capital Management
Goldman Sachs Group
State Street Corporation
Essex Woodlands Health Ventures

View all funds holding Eyepoint Pharmaceuticals